Search Results 601-610 of 16702 for mesenteric fat and ibd

  1. A Study to Analyze AVB-114 to Treat Complex Crohn’s Perianal Fistulas in Subjects with Quiescent Rectal Disease - Mayo Clinic

    It also aims to assess clinical and radiologic components of fistula remission, safety of treatment, disease activity, patient Quality of Life, and patient care ...

  2. Science Saturday: Mayo Clinic scientists identify a new way the liver cells break down fat

    Lipids, or “fat,” can be pulled out of the bloodstream by liver cells called hepatocytes. The fat accumulates within structures called lipid droplets. In a ...

  3. Gastroenterology and Hepatology - Clinical trials

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  4. Mesenteric ischemia - Doctors and departments - Mayo Clinic

    This condition can come on suddenly or develop over time. Find out more about symptoms and treatment for this condition that restricts blood flow to the ...

  5. Small bowel cancer - Doctors and departments - Mayo Clinic

    This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.

  6. A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Mayo Clinic

    A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) · More about research at Mayo Clinic · Mayo ...

  7. Clinical trials - Gastroenterology and Hepatology

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  8. Small bowel cancer - Doctors and departments - Mayo Clinic

    This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.

  9. Risks of Perinephric Fat Thickness on Adverse Renal Outcomes Post Donor Nephrectomy - Mayo Clinic

    The purpose of this study is to compare pro-inflammatory and pro-fibrotic cytokines expression in 40 Living kidney donors (LKDs), stratified by low PRAT ...

  10. Lipid Droplet Biology and Fatty Liver - Membrane Trafficking in Disease - Mayo Clinic Research

    Mayo Clinic's Membrane Trafficking in Disease Lab under Mark A. McNiven, Ph.D., studies lipid droplet biology, fatty liver disease and hepatic steatosis.